We suggest that the NIAM mutant mice described in this study represent a unique model of B-cell lymphoma that should help resolve NIAM's biological role in p53 signaling and other cancer pathways. This evidence concerns the gene TBRG1 and B-cell non-Hodgkin lymphoma.